Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of [Azilect] Rasagiline in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China

Trial Profile

Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of [Azilect] Rasagiline in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Sep 2014

At a glance

  • Drugs Rasagiline (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms CHORAL
  • Sponsors Lundbeck A/S
  • Most Recent Events

    • 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 28 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top